Literature DB >> 2771626

Effect of albumin distribution. A simulation analysis of the effect of altered albumin distribution on the apparent volume of distribution and apparent elimination rate constant of drugs.

M Shimoda1, E Kokue, T Hayama, T B Vree.   

Abstract

The effects of altered albumin distribution on the apparent volume of distribution (V) and the apparent elimination rate constant (kappa) of drugs were investigated by a simulation analysis. The Equations derived by Oie et al. were modified for this purpose. Within the range observed in normal healthy subjects and patients, the change in albumin distribution significantly affected V of drugs but, in general, not kappa. For drugs with more than 90% plasma-protein binding, V changed by more than 100%. The change in plasma-protein binding caused by an altered albumin distribution produced a greater effect on V than that caused by an altered albumin amount. These results suggest that albumin distribution is an important factor in controlling the kinetics of drugs which are highly bound to plasma protein. This is illustrated using midazolam as an example.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2771626     DOI: 10.1007/BF02110255

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  27 in total

1.  Role of concentration-dependent plasma protein binding in disopyramide disposition.

Authors:  P J Meffin; E W Robert; R A Winkle; S Harapat; F A Peters; D C Harrison
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

2.  The distribution of proteins between intra- and extravascular spaces in health and disease.

Authors:  L O Plantin; S Ahlinder; R Norberg; G Birke
Journal:  Acta Med Scand       Date:  1971-04

3.  Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?

Authors:  H Oldenhof; M de Jong; A Steenhoek; R Janknegt
Journal:  Clin Pharmacol Ther       Date:  1988-03       Impact factor: 6.875

Review 4.  Pharmacokinetics in renal failure.

Authors:  C Nancarrow; L E Mather
Journal:  Anaesth Intensive Care       Date:  1983-11       Impact factor: 1.669

5.  Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism.

Authors:  J H Lin; K F Hooke; K C Yeh; D E Duggan
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

6.  The influence of protein binding on the pharmacokinetics of sulphadimethoxine in rabbits.

Authors:  O Ladefoged
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-07

7.  The binding capacity of albumin and renal disease.

Authors:  S H Dromgoole
Journal:  J Pharmacol Exp Ther       Date:  1974-11       Impact factor: 4.030

8.  Effect of altered plasma protein binding on apparent volume of distribution.

Authors:  S Oie; T N Tozer
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

9.  Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

10.  Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.

Authors:  M S Dirksen; T B Vree; J J Driessen
Journal:  Anaesth Intensive Care       Date:  1987-11       Impact factor: 1.669

View more
  2 in total

1.  In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis.

Authors:  Anne Plum; Lisbeth Bjerring Jensen; Jesper Bøggild Kristensen
Journal:  J Pharm Sci       Date:  2013-07-12       Impact factor: 3.534

2.  Bioaccessibility and Pharmacokinetics of a Commercial Saffron (Crocus sativus L.) Extract.

Authors:  Paula Almodóvar; David Briskey; Amanda Rao; Marín Prodanov; Antonio M Inarejos-García
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-30       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.